The Cigna Group vs Elevance Health, Inc.
A head-to-head of The Cigna Group (CI) and Elevance Health, Inc. (ELV) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | CI | ELV |
|---|---|---|
| Market Cap | $74.45B | $80.92B |
| P/E (TTM) | 11.93 | 16.58 |
| Forward P/E | 8.45 | 12.58 |
| P/S | 0.27 | 0.39 |
| P/B | 2.69 | 1.80 |
| EV/EBITDA | 7.49 | 0.00 |
| Dividend Yield | 1.41% | 1.86% |
| Profit Margin | 2.26% | 2.47% |
| Gross Margin | — | 25.56% |
| Operating Margin | — | 4.07% |
| Revenue Growth (YoY) | +4.96% | +1.40% |
| FCF Yield | 10.23% | 8.19% |
| Debt / Equity | 72.81 | 68.95 |
| Current Ratio | 0.82 | 1.48 |
Which is better: The Cigna Group or Elevance Health, Inc.?
- ✓Larger by market cap: Elevance Health, Inc.
- ✓Cheaper valuation (lower P/E): The Cigna Group
- ✓Higher dividend yield: Elevance Health, Inc.
- ✓More profitable (net margin): Elevance Health, Inc.
- ✓Faster revenue growth: The Cigna Group
- ✓Higher free-cash-flow yield: The Cigna Group
Very close — each leads on 5 metrics.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.